JCR initiates phase II trial of JR-142 in pediatric patients with growth hormone deficiency May 19, 2021
Ascendis reports 58-week data from phase II OLE study of TransCon PTH in hypoparathyroidism May 11, 2021
Natural language processing identifies impact of diazoxide choline on Prader-Willi syndrome May 11, 2021
RSS